Priyank J. Shah

Array ( [id] => 1217242 [patent_doc_number] => 06706861 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-03-16 [patent_title] => 'Reconstitution of purified membrane proteins into preformed liposomes' [patent_app_type] => B2 [patent_app_number] => 09/815195 [patent_app_country] => US [patent_app_date] => 2001-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7758 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/706/06706861.pdf [firstpage_image] =>[orig_patent_app_number] => 09815195 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1331841 [patent_doc_number] => 06596543 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-07-22 [patent_title] => 'Use of liposomes of defined composition and size for the preparation of prothrombin time reagents' [patent_app_type] => B2 [patent_app_number] => 09/815398 [patent_app_country] => US [patent_app_date] => 2001-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4299 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/596/06596543.pdf [firstpage_image] =>[orig_patent_app_number] => 09815398 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7060991 [patent_doc_number] => 20050003352 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-06 [patent_title] => 'PRODUCTION OF ADENINE NUCLEOTIDE TRANSLOCATOR (ANT), NOVEL ANT LIGANDS AND SCREENING ASSAYS THEREFOR' [patent_app_type] => utility [patent_app_number] => 09/809827 [patent_app_country] => US [patent_app_date] => 2001-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 35500 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20050003352.pdf [firstpage_image] =>[orig_patent_app_number] => 09809827 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7060992 [patent_doc_number] => 20050003353 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-06 [patent_title] => 'PRODUCTION OF ADENINE NUCLEOTIDE TRANSLOCATOR (ANT), NOVEL ANT LIGANDS AND SCREENING ASSAYS THEREFOR' [patent_app_type] => utility [patent_app_number] => 09/809889 [patent_app_country] => US [patent_app_date] => 2001-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 35504 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20050003353.pdf [firstpage_image] =>[orig_patent_app_number] => 09809889 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 773151 [patent_doc_number] => 07001729 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-02-21 [patent_title] => 'Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor' [patent_app_type] => utility [patent_app_number] => 09/811131 [patent_app_country] => US [patent_app_date] => 2001-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 20 [patent_no_of_words] => 35580 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/001/07001729.pdf [firstpage_image] =>[orig_patent_app_number] => 09811131 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7612926 [patent_doc_number] => 06902908 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-06-07 [patent_title] => 'Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor' [patent_app_type] => utility [patent_app_number] => 09/811094 [patent_app_country] => US [patent_app_date] => 2001-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 20 [patent_no_of_words] => 35592 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/902/06902908.pdf [firstpage_image] =>[orig_patent_app_number] => 09811094 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1021236 [patent_doc_number] => 06887670 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-05-03 [patent_title] => 'Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor' [patent_app_type] => utility [patent_app_number] => 09/811132 [patent_app_country] => US [patent_app_date] => 2001-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 20 [patent_no_of_words] => 35558 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/887/06887670.pdf [firstpage_image] =>[orig_patent_app_number] => 09811132 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1157900 [patent_doc_number] => 06762286 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-07-13 [patent_title] => 'Modified vitamin K-dependent polypeptides' [patent_app_type] => B2 [patent_app_number] => 09/803810 [patent_app_country] => US [patent_app_date] => 2001-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 24 [patent_no_of_words] => 17641 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/762/06762286.pdf [firstpage_image] =>[orig_patent_app_number] => 09803810 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1021700 [patent_doc_number] => 06887845 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-05-03 [patent_title] => 'Polypeptoid pulmonary surfactants' [patent_app_type] => utility [patent_app_number] => 09/788308 [patent_app_country] => US [patent_app_date] => 2001-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 20 [patent_no_of_words] => 11062 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/887/06887845.pdf [firstpage_image] =>[orig_patent_app_number] => 09788308 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6242182 [patent_doc_number] => 20020045211 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-18 [patent_title] => 'Direct expression of peptides into culture media' [patent_app_type] => new [patent_app_number] => 09/780643 [patent_app_country] => US [patent_app_date] => 2001-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 14903 [patent_no_of_claims] => 101 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20020045211.pdf [firstpage_image] =>[orig_patent_app_number] => 09780643 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1296961 [patent_doc_number] => 06627438 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-09-30 [patent_title] => 'Direct expression of peptides into culture media' [patent_app_type] => B2 [patent_app_number] => 09/780878 [patent_app_country] => US [patent_app_date] => 2001-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 38 [patent_no_of_words] => 14670 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/627/06627438.pdf [firstpage_image] =>[orig_patent_app_number] => 09780878 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 425273 [patent_doc_number] => 07271256 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-09-18 [patent_title] => 'Method for producing circular or multimeric protein species in vivo or in vitro and related methods' [patent_app_type] => utility [patent_app_number] => 09/937070 [patent_app_country] => US [patent_app_date] => 2001-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9130 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/271/07271256.pdf [firstpage_image] =>[orig_patent_app_number] => 09937070 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6912236 [patent_doc_number] => 20050175994 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-11 [patent_title] => 'Methods and materials relating to prothrombinase-like polypeptides and polynucleotides' [patent_app_type] => utility [patent_app_number] => 10/311827 [patent_app_country] => US [patent_app_date] => 2000-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 46757 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20050175994.pdf [firstpage_image] =>[orig_patent_app_number] => 10311827 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6761888 [patent_doc_number] => 20030125250 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-03 [patent_title] => 'Medicinal compositions for preventing and treating hemorrhagic diseases associating thrombopathy' [patent_app_type] => new [patent_app_number] => 10/168727 [patent_app_country] => US [patent_app_date] => 2002-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2696 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0125/20030125250.pdf [firstpage_image] =>[orig_patent_app_number] => 10168727 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6224497 [patent_doc_number] => 20020004228 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-10 [patent_title] => 'Zvwf1: a member of the von willebrand factor type A domain superfamily' [patent_app_type] => new [patent_app_number] => 09/732227 [patent_app_country] => US [patent_app_date] => 2000-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29999 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20020004228.pdf [firstpage_image] =>[orig_patent_app_number] => 09732227 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 723856 [patent_doc_number] => 07045280 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-16 [patent_title] => 'Assay method' [patent_app_type] => utility [patent_app_number] => 10/130368 [patent_app_country] => US [patent_app_date] => 2000-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4277 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/045/07045280.pdf [firstpage_image] =>[orig_patent_app_number] => 10130368 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1271670 [patent_doc_number] => 06653449 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-25 [patent_title] => 'Hemolytic active proteins and genes encoding the same' [patent_app_type] => B1 [patent_app_number] => 09/647522 [patent_app_country] => US [patent_app_date] => 2000-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8081 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/653/06653449.pdf [firstpage_image] =>[orig_patent_app_number] => 09647522 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6621842 [patent_doc_number] => 20020065214 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-30 [patent_title] => 'Method of treating congestive heart failure' [patent_app_type] => new [patent_app_number] => 09/725161 [patent_app_country] => US [patent_app_date] => 2000-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1636 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20020065214.pdf [firstpage_image] =>[orig_patent_app_number] => 09725161 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1337208 [patent_doc_number] => 06593294 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-15 [patent_title] => 'Pharmaceutical composition comprising Factor VIII and neutral liposomes' [patent_app_type] => B1 [patent_app_number] => 09/673412 [patent_app_country] => US [patent_app_date] => 2000-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4674 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/593/06593294.pdf [firstpage_image] =>[orig_patent_app_number] => 09673412 [rel_patent_id] =>[rel_patent_doc_number] =>)